Robert Dishman Email & Phone Number

Bob Dishman is a scientist with a long history as a successful biotech operating executive and entrepreneur. In the course of his 30+ years of experience, Bob has become recognized as a leading expert in running biotech companies engaged in drug discovery based on bioseparation, purification, and combinatorial chemistry. Bob is perhaps best known as COO of Sepracor, Inc., managing its work in the "pure isomer" form of major pharmaceuticals, and as the founder and CEO of Arqule, Inc., one of the early combinatorial chemistry companies, both of which went public. In addition, Bob was the President and Founder of the Milligen Division of Millipore, focused on DNA and peptide synthesizers and sequencers for analysis and synthesis of biological molecules, and CEO of Biotage, Inc., a company he helped re-direct take public as Dyax Corp. More recently, Bob has been CEO, Chairman or Board member of four other biotech companies both public and private. Dr. Dishman holds a Ph.D. in Analytical Chemistry, a MS in Chemistry, both from the University of Massachusetts, Amherst, and a BS from the University of New Hampshire, Durham.

Listed skills include Biotechnology.